INKT - MiNK Therapeutics GAAP EPS of $0.19 November, 03 2022 08:03 AM MiNK Therapeutics Inc. MiNK Therapeutics press release ( NASDAQ: INKT ): Q3 GAAP EPS of $0.19. We ended the third quarter 2022 with a cash balance of $24.2 million as compared to $38.9 million at December 31, 2021. For further details see: MiNK Therapeutics GAAP EPS of $0.19